Evaluation of Fibrin Structure Marker in Cancer Patients Treated and Not Treated With LMWH (FICT)
Sponsor: Diagnostica Stago R&D
Listed as NCT02552381, this observational or N/A phase trial focuses on Malignant Tumor and remains completed. Sponsored by Diagnostica Stago R&D, it has been updated 14 times since 2015, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
14 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2021 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Dec 2021 [monthly]
Completed
-
Nov 2020 — Jan 2021 [monthly]
Completed
▶ Show 9 earlier versions
-
Feb 2020 — Nov 2020 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Aug 2019 — Feb 2020 [monthly]
Active Not Recruiting
Status: Unknown Status → Active Not Recruiting
-
May 2019 — Aug 2019 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Jun 2018 — May 2019 [monthly]
Recruiting
-
May 2018 — Jun 2018 [monthly]
Recruiting
-
Apr 2018 — May 2018 [monthly]
Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Recruiting NA
-
Jun 2017 — Aug 2017 [monthly]
Recruiting NA
-
Jan 2017 — Jun 2017 [monthly]
Recruiting NA
First recorded
Aug 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Diagnostica Stago R&D
- Hopital Lariboisière
- Hôpital Louis Mourier
For direct contact, visit the study record on ClinicalTrials.gov .